One colour per peptide

Vials arrive pre-mixed — no powder to reconstitute

  • 99%+ HPLC-verified
  • COA with every order
  • Same-day UK dispatch

What is Glow peptide?

9 min read · Updated September 2026 · MY PEPTIDES Research Team

Key facts

Glow peptide is the common name for a three-compound research blend supplied as a single pre-mixed vial: BPC-157 (10mg), TB-500 (10mg) and GHK-Cu (50mg), 70mg total. We list it as the Glow Stack, but the name is a market convention rather than a trademark, so the composition — and particularly the mass split — is what identifies the material, not the label. BPC-157 is studied as a probe for peptide-mediated signalling; TB-500, a thymosin beta-4 fragment, is investigated for actin-binding behaviour and cytoskeletal organisation; GHK-Cu, a copper-peptide complex, is studied for copper-dependent signalling and peptide–metal interactions. Presenting the three in one standardised preparation lets researchers compare individual against combined activity without a reconstitution step between the certificate and the experiment. Each component is HPLC-verified per batch, with certificates published in our COA library, and the vial is stored refrigerated at 2–8°C. Supplied strictly for in-vitro laboratory research — not for human or veterinary use, and carrying no therapeutic or cosmetic claims.

Glow peptide is the common name for a three-compound research blend supplied as a single pre-mixed vial: BPC-157 (10mg), TB-500 (10mg) and GHK-Cu (50mg), 70mg total. We list it as the Glow Stack, and elsewhere you will see it as GLOW, the glow blend or glow peptide 70mg — all referring to the same three compounds in one solution. Presenting them together lets researchers examine combined peptide activity, cross-pathway interactions and individual-versus-blended behaviour within a single experimental system, with each component HPLC-verified per batch.

Research use only. Glow peptide is supplied strictly for in-vitro laboratory research. This page does not describe dosing, administration, or use in humans or animals, and makes no therapeutic or cosmetic claims.

What "glow peptide" actually refers to

The term is a usage convention, not a formal or trademarked name. Nobody owns it, no standards body defines it, and there is no registered composition behind it — which means two suppliers can both sell something called glow peptide and ship materially different vials.

What varies is the split rather than the compound list. The three components are stable across the market; the mass allocated to each is not, and neither is the total. Ours is 70mg because GHK-Cu carries 50mg of it, with BPC-157 and TB-500 at 10mg each. A "glow" vial at a different total is a different preparation, and any result taken from one does not transfer cleanly to the other.

That is the single most useful thing to know about the name: treat it as a description of the contents, and check the contents. For research purposes the composition is the compound, and a label without one cannot be sourced, verified or replicated.

What is in Glow peptide

ComponentMassWhat the literature examines
BPC-15710mgA synthetic pentadecapeptide sequence, used widely as a probe for peptide-mediated signalling, including nitric-oxide-related and growth-factor-related pathways
TB-50010mgA synthetic fragment of thymosin beta-4, a 43-residue protein, studied for actin-binding behaviour, cell migration and cytoskeletal organisation
GHK-Cu50mgA copper-peptide complex — glycyl-L-histidyl-L-lysine bound to a divalent copper ion — studied for copper-dependent signalling and peptide–metal interactions

The mass is not evenly split. GHK-Cu accounts for roughly five-sevenths of the material and the other two share the remainder equally. That distribution matters when interpreting anything observed in the combined preparation, because the copper-peptide complex dominates by mass, and it is the first figure to compare when reading one supplier's glow blend against another's.

Each compound has its own guide if you need the detail: GHK-Cu, which is by far the most-published of the three, and BPC-157.

Why the three are combined

The research rationale for a multi-compound vial is that the three have distinct and largely non-overlapping mechanisms — copper-dependent signalling, cytoskeletal and actin dynamics, and a general peptide-signalling probe. Presenting them in one preparation supports two kinds of question that three separate vials make awkward to ask.

The first is convergent signalling: whether pathways usually studied in isolation behave differently when present in the same system, and whether a combined response differs from the sum of the individual ones. The second is comparison under standardised conditions: running the blend against its components requires the components to be identical material at a known ratio, which a pre-combined preparation from a single batch gives you and three separately reconstituted vials do not.

Typical applications are multi-peptide signalling studies, cytoskeletal and cell-migration research, and analytical work on peptide stability and compatibility in blended systems.

No combined effect is claimed. The three are supplied together as a research convenience — a controlled, documented starting material — and not on the basis that the combination produces any particular outcome.

What "pre-mixed" means here

Most research peptides ship as lyophilised powder that the end user reconstitutes. Glow peptide ships as a solution at a known concentration, prepared and documented under controlled conditions, so that step is already done.

The distinction matters more for a blend than for a single compound. Reconstitution is where avoidable variability enters — water choice, added volume, mixing technique and the delay before first use all differ between benches — and with three compounds it enters three times, along with the possibility of a ratio that drifts from the intended one. A pre-combined solution removes that: what is in the vial is what the batch record says is in the vial, and the ratio between the three is fixed at preparation rather than assembled at the bench.

The trade is that a solution has a shorter usable life than a sealed powder and depends on the cold chain, which is why it ships refrigerated. Our guide on storing research peptides covers the handling side.

How each batch is tested

Purity is measured by high-performance liquid chromatography (HPLC) per component, per batch, and the figure recorded is the value the laboratory measured for that lot — not a generic number reprinted across every batch.

Because this is a multi-compound set rather than a single compound, the documentation works slightly differently from a single-peptide vial: certificates are issued per component, and they are published in our COA library so the format can be reviewed before ordering rather than after. That is the honest description of what a blend certificate can and cannot be — a single purity figure for a three-compound solution would not mean very much, because it would not tell you which compound the figure belongs to.

If you are new to reading these documents, what a Certificate of Analysis is sets out the format in full.

What to check on the certificate

  • A measured purity figure, not a marketing one. A per-lot value beats "99%+" repeated everywhere.
  • A batch identifier that matches the vial. A certificate you cannot tie to the material in front of you documents somebody else's material.
  • The analytical method. HPLC for purity, mass spectrometry for identity. A number with no method attached is not evidence.
  • A date. Peptide material is not indefinitely stable, and an undated certificate cannot tell you where a lot sits in its life.
  • Coverage of all three components. For a blend, one certificate is not enough — you want the set.

Glow, KLOW and Wolverine compared

The three pre-combined sets we supply differ in how many compounds they carry and, more importantly, in the mass split:

SetComponentsTotal
WolverineBPC-157, TB-50020mg
GlowBPC-157, TB-500, GHK-Cu (50mg)70mg
KLOWBPC-157, TB-500, GHK-Cu, KPV (10mg)80mg

Read down the list and the relationship is straightforward: Wolverine is the BPC-157/TB-500 pairing on its own, Glow adds GHK-Cu, and KLOW adds the α-MSH fragment KPV on top of Glow. The 50mg of GHK-Cu is what separates Glow from Wolverine, and it is why Glow appears in copper-peptide and matrix-research contexts that the two-compound set does not.

Storage and handling

Store refrigerated at 2–8°C. No reconstitution step is required.

Copper-peptide complexes are more sensitive than plain short peptides, for a reason specific to the chemistry: the property being studied depends on copper staying coordinated to the peptide, so conditions that disturb that coordination change what is in the vial. pH governs the coordination directly, and a redox-active metal makes oxidation and light exposure matter more than they would for an uncomplexed peptide. Repeated warming and cooling is worse than continuous cold.

The colour is a useful informal check. A GHK-Cu-containing solution is a distinct blue, and the depth of that colour tracks the copper coordination — a vial that has gone colourless, green or brown is telling you something about the state of the material. It is not a substitute for an assay, but it is the first thing an experienced hand looks at.

Glow peptide and skincare

A large share of the search interest in the term arrives from skincare, because GHK-Cu appears widely in cosmetic-chemistry writing and because the name invites the association. It is worth being blunt about how the two relate, because they are not interchangeable.

Cosmetic serums containing copper tripeptide are finished consumer products: formulated at low concentration in a vehicle designed for topical application, regulated as cosmetics, manufactured to that standard, and generally sold without a measured concentration or batch analysis.

Glow peptide is a characterised research material. It is supplied with batch analytical documentation for in-vitro laboratory work, it is not formulated for application to skin, it is not manufactured or regulated as a cosmetic, and it is not a cosmetic product.

We do not supply Glow peptide for cosmetic or personal use, and material bought here should not be used that way. If you are looking for a skincare product, a regulated cosmetic from a cosmetics manufacturer is the correct thing to buy, and this is not it. We make no claim about appearance, skin or any other outcome in a person.

Dosing and administration

We do not publish dosing, preparation-for-use or administration guidance for Glow peptide, and that is a deliberate position rather than an omission. The material is supplied for in-vitro laboratory research and is not for human or veterinary use, so quantity guidance aimed at a person would be inconsistent with what is actually being sold.

Experimental concentrations for cell-culture work are specific to the model, the endpoint and the protocol — published GHK-Cu work alone spans several orders of magnitude — and belong in the primary literature rather than on a supplier's page.

What Glow peptide is not

  • It is not an approved medicine in the UK or anywhere else, and is not supplied for human use.
  • It is not a cosmetic, and is not supplied or regulated as one.
  • It is not a defined or standardised product across the market. The name fixes the compounds loosely and the ratio not at all.
  • Published in-vitro findings on the individual components do not transfer straightforwardly to whole organisms, and findings on one component are not findings on the blend.

How it is supplied

The Glow Stack is supplied as a pre-mixed 70mg vial — BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg — with no reconstitution step, batch documentation, and refrigerated storage at 2–8°C.

If you need the components individually rather than combined, each is available on its own: BPC-157, TB-500 and GHK-Cu. For UK supply details — strengths, batch documentation, dispatch and trade volumes — see the Glow Stack product page.

Related reading

GLOW Peptide Stack — BPC-157, TB-500 & GHK-Cu

Available now from MY PEPTIDES — 99%+ purity, COA with every order, fast UK dispatch.

Buy GLOW Peptide Stack — BPC-157, TB-500 & GHK-Cu

Frequently asked questions

What is Glow peptide?
Glow peptide is the common name for a three-compound research blend supplied as a single pre-mixed vial: BPC-157 (10mg), TB-500 (10mg) and GHK-Cu (50mg), 70mg total. We list it as the Glow Stack. It is supplied strictly for in-vitro laboratory research — not for human or veterinary use — and carries no therapeutic or cosmetic claims.
Is Glow peptide the same as the Glow Stack?
Yes. "Glow peptide", "GLOW" and "the glow blend" are market shorthand for the same three-compound preparation we list as the Glow Stack. The name is a usage convention rather than a trademark, so it is worth checking the composition and the mass split rather than relying on the label — different suppliers use the name for vials with different totals.
What is in Glow peptide?
BPC-157 (10mg), TB-500 (10mg) and GHK-Cu (50mg) — 70mg total in one pre-mixed vial. The mass is not evenly split: GHK-Cu, a copper-peptide complex, accounts for roughly five-sevenths of the material. That ratio is the first thing to compare when reading one glow blend against another.
What is the difference between Glow and KLOW?
KLOW is Glow with the α-MSH fragment KPV added: GHK-Cu, KPV, BPC-157 and TB-500 at 80mg total, against the three compounds in Glow at 70mg. The Wolverine Stack is the other direction — BPC-157 and TB-500 only, at 20mg, without the GHK-Cu.
Does Glow peptide come with a Certificate of Analysis?
Yes, and because this is a multi-compound set the certificates are issued per component rather than as a single combined figure — a lone purity number for a three-compound solution would not tell you which compound it belonged to. Purity is measured by HPLC per batch. Recent certificates are published in our COA library so the format can be reviewed before ordering.
Can I buy the components separately?
Yes — BPC-157, TB-500 and GHK-Cu are each available individually. The blend exists as a research convenience: one batch, one documented preparation and a fixed ratio, which is what makes comparing combined against individual activity practical. All are supplied for research use only.
Is Glow peptide a skincare product?
No. It is a research material supplied with batch analytical documentation for in-vitro laboratory work. It is not formulated for application to skin, is not manufactured or regulated as a cosmetic, and we do not supply it for cosmetic or personal use. Cosmetic serums containing copper tripeptide are separate, regulated consumer products, and this is not one.
What dose of Glow peptide should be used?
We do not publish dosing or administration guidance. Glow peptide is supplied strictly for in-vitro laboratory research and is not for human or veterinary use, so quantity guidance aimed at a person would be inconsistent with what is supplied. Experimental concentrations in published cell-culture work are specific to the model and endpoint, so the primary literature is the right source for protocol design.
How should Glow peptide be stored?
Refrigerated at 2–8°C. It is supplied pre-mixed rather than as a lyophilised powder, so no reconstitution step is needed. Copper-peptide complexes are more sensitive to pH, light and oxidation than plain short peptides, and repeated warming and cooling is worse than continuous cold.